Fibrinogen-like protein 1, a hepatocyte derived protein is an acute phase reactant

Biochemical and Biophysical Research Communications

Volumn 365, Issue 4, 2008, Pages 729-734

  Liu, Zhilin ^a   Ukomadu, Chinweike ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Acute phase; Fibrinogen; Fibrinogen like protein 1; Inflammation; Interleukin 6; Liver regeneration; Serum amyloid; Turpentine

Indexed keywords

ACUTE PHASE PROTEIN; AMYLOID A PROTEIN; AMYLOID PROTEIN; BIOLOGICAL MARKER; FIBRIN; INTERLEUKIN 6; PROTEIN FGL1; TURPENTINE OIL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CELL PROLIFERATION; CELL STRAIN HEPG2; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; LIVER CELL CARCINOMA; LIVER INJURY; LIVER REGENERATION; MALE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RAT;

ACUTE-PHASE PROTEINS; ACUTE-PHASE REACTION; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION, NEOPLASTIC; HEPATOCYTES; HUMANS; INTERLEUKIN-6; NEOPLASM PROTEINS;

RATTUS; RODENTIA;

EID: 36849018082     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.11.069     Document Type: Article

References (27)

1. Heinrich P.C., Castell J.V., and Andus T. Interleukin-6 and the acute phase response. Biochem. J. 265 (1990) 621-636
2. Kushner I. The acute phase response: an overview. Methods Enzymol. 163 (1988) 373-383
3. Koj A. Biological functions of acute-phase proteins. In: Gordon A.H., and Koj A. (Eds). The Acute Phase Response to Injury and Infection (1985), Elsheiver Science, New York 145-160
4. Gertz M.A., and Kyle R.A. Secondary systemic amyloidosis: response and survival in 64 patients. Medicine (Baltimore) 70 (1991) 246-256
5. Nemeth E., Valore E.V., Territo M., Schiller G., Lichtenstein A., and Ganz T. Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood 101 (2003) 2461-2463
6. Taub R. Liver regeneration: from myth to mechanism. Nat. Rev. Mol. Cell Biol. 5 (2004) 836-847
7. Geiger T., Andus T., Klapproth J., Hirano T., Kishimoto T., and Heinrich P.C. Induction of rat acute-phase proteins by interleukin 6 in vivo. Eur. J. Immunol. 18 (1988) 717-721
8. Marinkovic S., Jahreis G.P., Wong G.G., and Baumann H. IL-6 modulates the synthesis of a specific set of acute phase plasma proteins in vivo. J. Immunol. 142 (1989) 808-812
9. Gauldie J., Richards C., Harnish D., Lansdorp P., and Baumann H. Interferon beta 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells. Proc. Natl. Acad. Sci. USA 84 (1987) 7251-7255
10. Yamamoto T., Gotoh M., Sasaki H., Terada M., Kitajima M., and Hirohashi S. Molecular cloning and initial characterization of a novel fibrinogen-related gene, HFREP-1. Biochem. Biophys. Res. Commun. 193 (1993) 681-687
11. Hara H., Uchida S., Yoshimura H., Aoki M., Toyoda Y., Sakai Y., Morimoto S., Fukamachi H., Shiokawa K., and Hanada K. Isolation and characterization of a novel liver-specific gene, hepassocin, upregulated during liver regeneration. Biochim. Biophys. Acta 1492 (2000) 31-44
12. Hara H., Yoshimura H., Uchida S., Toyoda Y., Aoki M., Sakai Y., Morimoto S., and Shiokawa K. Molecular cloning and functional expression analysis of a cDNA for human hepassocin, a liver-specific protein with hepatocyte mitogenic activity. Biochim. Biophys. Acta 1520 (2001) 45-53
13. Hill D.B., Schmidt J., Shedlofsky S.I., Cohen D.A., and McClain C.J. In vitro tumor necrosis factor cytotoxicity in Hep G2 liver cells. Hepatology 21 (1995) 1114-1119
14. Ukomadu C., and Dutta A. p21-dependent inhibition of colon cancer cell growth by mevastatin is independent of inhibition of G1 cyclin-dependent kinases. J. Biol. Chem. 278 (2003) 43586-43594
15. Yan J., Ying H., Gu F., He J., Li Y.L., Liu H.M., and Xu Y.H. Cloning and characterization of a mouse liver-specific gene mfrep-1, up-regulated in liver regeneration. Cell Res. 12 (2002) 353-361
16. Snyers L., Fontaine V., and Content J. Modulation of interleukin-6 receptors in human cells. Ann. NY Acad. Sci. 557 (1989) 388-393 discussion 394-5
17. Fischer C.P., Bode B.P., Takahashi K., Tanabe K.K., and Souba W.W. Glucocorticoid-dependent induction of interleukin-6 receptor expression in human hepatocytes facilitates interleukin-6 stimulation of amino acid transport. Ann. Surg. 223 (1996) 610-618 discussion 618-9
18. Helfgott D.C., May L.T., Sthoeger Z., Tamm I., and Sehgal P.B. Bacterial lipopolysaccharide (endotoxin) enhances expression and secretion of beta 2 interferon by human fibroblasts. J. Exp. Med. 166 (1987) 1300-1309
19. Kohase M., Henriksen-Destefano D., Sehgal P.B., and Vilcek J. Dexamethasone inhibits feedback regulation of the mitogenic activity of tumor necrosis factor, interleukin-1, and epidermal growth factor in human fibroblasts. J. Cell Physiol. 132 (1987) 271-278
20. Rijken D.C., Dirkx S.P., Luider T.M., and Leebeek F.W. Hepatocyte-derived fibrinogen-related protein-1 is associated with the fibrin matrix of a plasma clot. Biochem. Biophys. Res. Commun. 350 (2006) 191-194
21. Yan J., Yu Y., Wang N., Chang Y., Ying H., Liu W., He J., Li S., Jiang W., Li Y., Liu H., Wang H., and Xu Y. LFIRE-1/HFREP-1, a liver-specific gene, is frequently downregulated and has growth suppressor activity in hepatocellular carcinoma. Oncogene 23 (2004) 1939-1949
22. Wegenka U.M., Buschmann J., Lutticken C., Heinrich P.C., and Horn F. Acute-phase response factor, a nuclear factor binding to acute-phase response elements, is rapidly activated by interleukin-6 at the posttranslational level. Mol. Cell Biol. 13 (1993) 276-288
23. Zhong Z., Wen Z., and Darnell Jr. J.E. Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6. Science 264 (1994) 95-98
24. Kim I., Kim H.G., Kim H., Kim H.H., Park S.K., Uhm C.S., Lee Z.H., and Koh G.Y. Hepatic expression, synthesis and secretion of a novel fibrinogen/angiopoietin-related protein that prevents endothelial-cell apoptosis. Biochem. J. 346 Pt 3 (2000) 603-610
25. Procopio W.N., Pelavin P.I., Lee W.M., and Yeilding N.M. Angiopoietin-1 and -2 coiled coil domains mediate distinct homo-oligomerization patterns, but fibrinogen-like domains mediate ligand activity. J. Biol. Chem. 274 (1999) 30196-30201
26. Sahni A., and Francis C.W. Vascular endothelial growth factor binds to fibrinogen and fibrin and stimulates endothelial cell proliferation. Blood 96 (2000) 3772-3778
27. El-Karef A., Yoshida T., Gabazza E.C., Nishioka T., Inada H., Sakakura T., and Imanaka-Yoshida K. Deficiency of tenascin-C attenuates liver fibrosis in immune-mediated chronic hepatitis in mice. J. Pathol. 211 (2007) 86-94